N-(3,4-Dimethylphenyl)-2-((4-(3-phenylthioureido)phenyl)thio)acetamide

Catalog No. :
ACQXRL489
CAS No. :
763128-88-7
Molecular Formula :
C23H23N3OS2
Molecular Weight :
421.59

IUPAC Name:N-(3,4-dimethylphenyl)-2-((4-(3-phenylthioureido)phenyl)thio)acetamide

N-(3,4-Dimethylphenyl)-2-((4-(3-phenylthioureido)phenyl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3,4-Dimethylphenyl)-2-((4-(3-phenylthioureido)phenyl)thio)acetamide
IUPAC NameN-(3,4-dimethylphenyl)-2-((4-(3-phenylthioureido)phenyl)thio)acetamide
MDL No.MFCD05155025
Molecular FormulaC23H23N3OS2
Molecular Weight421.59
SMILESO=C(NC1=CC=C(C)C(C)=C1)CSC2=CC=C(NC(NC3=CC=CC=C3)=S)C=C2
InChI KeyWJSARUBYFBWYRR-UHFFFAOYSA-N
Synonym2-({4-[(anilinocarbothioyl)amino]phenyl}sulfanyl)-N-(3,4-dimethylphenyl)acetamide;2-((4-((ANILINOCARBOTHIOYL)AMINO)PHENYL)THIO)-N-(3,4-DIMETHYLPHENYL)ACETAMIDE;Acetamide, N-(3,4-dimethylphenyl)-2-[[4-[[(phenylamino)thioxomethyl]amino]phenyl]thio]-
CAS No.763128-88-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACQXRL489 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQXRL489 route product structure diagram
    ACQXRL489763128-88-7
Inquiry

2. ACQXRL489 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHCWT056 route compound structure diagram
    ACHCWT0567356-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQXRL489 route product structure diagram
    ACQXRL489763128-88-7
Inquiry

Comments (0)